A carregar...
The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells
AIMS: To understand the mechanism by which imeglimin (a new oral hypoglycemic agent whose phase 3 development program in Japan has now been completed) decreases hepatic glucose production. MATERIALS AND METHODS: We compared the effect of imeglimin and metformin on glucose production, ATP/ADP ratio,...
Na minha lista:
| Publicado no: | Endocrinol Diabetes Metab |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029524/ https://ncbi.nlm.nih.gov/pubmed/33855213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.211 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|